The results of the present study expand the existing repertoire of CDK-independent activities of p27Kip1, and suggest that the increased cell-cycle transition due to p27Kip1 deficiency can synergize with increased expression of growth-promoting signals (e.g. EGFR) to accelerate tumour progression. This evidence concerns the gene EGFR and neoplasm.